• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活动性慢性肉样瘤病的特征是过渡性血液 B 细胞增加、产生白细胞介素-10 的调节性 B 细胞增加和 BAFF 水平升高。

Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels.

机构信息

INSERM U976, Paris, France.

出版信息

PLoS One. 2012;7(8):e43588. doi: 10.1371/journal.pone.0043588. Epub 2012 Aug 22.

DOI:10.1371/journal.pone.0043588
PMID:22927996
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3425471/
Abstract

BACKGROUND

Sarcoidosis is a multisystemic disease of unknown etiology characterized by a disproportionate Th1 granulomatous immune response in the organs involved. Plasmatic hypergammaglobulinemia and B cell accumulation in granulomatous lesions suggest the possible role of humoral immune responses in the pathogenesis of sarcoidosis. The purpose of this study is to describe B cell peripheral compartment in sarcoidosis.

METHODOLOGY/PRINCIPAL FINDINGS: We analyzed blood B cell subsets and BAFF levels in 33 patients with chronic sarcoidosis (active sarcoidosis n = 18; inactive sarcoidosis n = 15) and 18 healthy donors. Active chronic sarcoidosis patients had significantly less circulating memory B cells (p<0.01), more transitional (p<0.01) and increased numbers of IL-10-producing regulatory B cells (p<0.05) compared with healthy donors and patients with inactive sarcoidosis. BAFF serum levels were significantly higher in patients with active sarcoidosis (p<0.01 versus healthy donors and inactive sarcoidosis patients) and strongly correlated with serum hypergammaglobulinemia (r = 0.53, p<0.01) and angiotensin converting enzyme levels (r = 0.61, p = <0.01).

CONCLUSIONS/SIGNIFICANCE: These data show that there is an altered B cell homeostasis in active sarcoidosis and suggest BAFF antagonist drugs as potential new treatments of this disease.

摘要

背景

结节病是一种病因不明的多系统疾病,其特征是受累器官中存在不成比例的 Th1 肉芽肿性免疫反应。浆细胞性高丙种球蛋白血症和肉芽肿病变中 B 细胞的积累表明体液免疫反应可能在结节病的发病机制中起作用。本研究的目的是描述结节病的外周 B 细胞区室。

方法/主要发现:我们分析了 33 例慢性结节病患者(活动期结节病 n=18;非活动期结节病 n=15)和 18 名健康供体的血液 B 细胞亚群和 BAFF 水平。与健康供体和非活动期结节病患者相比,活动期慢性结节病患者的循环记忆 B 细胞明显减少(p<0.01),过渡性 B 细胞(p<0.01)和产生 IL-10 的调节性 B 细胞数量增加(p<0.05)。活动期结节病患者的 BAFF 血清水平明显高于健康供体和非活动期结节病患者(p<0.01),与血清高丙种球蛋白血症(r=0.53,p<0.01)和血管紧张素转换酶水平(r=0.61,p<0.01)强烈相关。

结论/意义:这些数据表明,活动期结节病存在 B 细胞稳态失衡,并提示 BAFF 拮抗剂药物可能成为这种疾病的新治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d75/3425471/a14480edbaa4/pone.0043588.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d75/3425471/8b3e663486bd/pone.0043588.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d75/3425471/6f0ee9fb99d6/pone.0043588.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d75/3425471/403a66ae3412/pone.0043588.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d75/3425471/a14480edbaa4/pone.0043588.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d75/3425471/8b3e663486bd/pone.0043588.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d75/3425471/6f0ee9fb99d6/pone.0043588.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d75/3425471/403a66ae3412/pone.0043588.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d75/3425471/a14480edbaa4/pone.0043588.g004.jpg

相似文献

1
Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels.活动性慢性肉样瘤病的特征是过渡性血液 B 细胞增加、产生白细胞介素-10 的调节性 B 细胞增加和 BAFF 水平升高。
PLoS One. 2012;7(8):e43588. doi: 10.1371/journal.pone.0043588. Epub 2012 Aug 22.
2
Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity.结节病患者血清 BAFF 水平升高:与疾病活动度相关。
Rheumatology (Oxford). 2013 Sep;52(9):1658-66. doi: 10.1093/rheumatology/ket186. Epub 2013 May 17.
3
Significant elevation of the levels of B-cell activating factor (BAFF) in patients with sarcoidosis.结节病患者 B 细胞激活因子(BAFF)水平显著升高。
Clin Rheumatol. 2018 Oct;37(10):2833-2838. doi: 10.1007/s10067-018-4183-2. Epub 2018 Jun 23.
4
BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance.BAFF 抑制通过调节调节性和效应性 B 细胞平衡来减轻硬皮病的纤维化。
Sci Adv. 2018 Jul 11;4(7):eaas9944. doi: 10.1126/sciadv.aas9944. eCollection 2018 Jul.
5
Serum IL-35 Levels Are Associated With Activity and Progression of Sarcoidosis.血清 IL-35 水平与结节病的活动和进展相关。
Front Immunol. 2020 May 19;11:977. doi: 10.3389/fimmu.2020.00977. eCollection 2020.
6
A serum B-lymphocyte activation signature is a key distinguishing feature of the immune response in sarcoidosis compared to tuberculosis.与结核相比,结节病患者血清 B 淋巴细胞激活特征是其区别于结核病的免疫反应的关键特征。
Commun Biol. 2024 Sep 10;7(1):1114. doi: 10.1038/s42003-024-06822-1.
7
Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.系统性红斑狼疮外周血B细胞亚群上BAFF、APRIL血清水平、BAFF-R、TACI和BCMA表达与临床表现的相关性
Lupus. 2016 May;25(6):582-92. doi: 10.1177/0961203315608254. Epub 2015 Sep 29.
8
B cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of Alopecia Areata.B细胞活化因子与辅助性T细胞17:斑秃发病机制中可能的协同致病因素
Arch Dermatol Res. 2016 Mar;308(2):115-21. doi: 10.1007/s00403-016-1617-z. Epub 2016 Jan 21.
9
Perigranuloma localization and abnormal maturation of B cells: emerging key players in sarcoidosis?肉芽肿旁定位和 B 细胞异常成熟:结节病中的新兴关键因素?
Am J Respir Crit Care Med. 2013 Feb 15;187(4):406-16. doi: 10.1164/rccm.201206-1024OC. Epub 2012 Dec 13.
10
Analysis of a large kindred with Blau syndrome for HLA, autoimmunity, and sarcoidosis.对一个患有布劳综合征的大家族进行HLA、自身免疫和结节病分析。
Am J Dis Child. 1993 Aug;147(8):842-8. doi: 10.1001/archpedi.1993.02160320044017.

引用本文的文献

1
Phenotypes and Endotypes in Sarcoidosis: Unraveling Prognosis and Disease Course.结节病的表型和内型:解读预后和疾病进程。
Biomedicines. 2025 Jan 24;13(2):287. doi: 10.3390/biomedicines13020287.
2
Sarcoidosis: molecular mechanisms and therapeutic strategies.结节病:分子机制与治疗策略
Mol Biomed. 2025 Feb 5;6(1):6. doi: 10.1186/s43556-025-00244-z.
3
Differential Diagnosis of Tuberculosis and Sarcoidosis by Immunological Features Using Machine Learning.利用机器学习通过免疫学特征对结核病和结节病进行鉴别诊断。

本文引用的文献

1
IL-10 producing regulatory B cells in mice and humans: state of the art.鼠和人体内产生 IL-10 的调节性 B 细胞:最新进展。
Curr Mol Med. 2012 Jun;12(5):519-27. doi: 10.2174/156652412800620057.
2
Disturbed homeostasis and multiple signaling defects in the peripheral blood B-cell compartment of patients with severe chronic sarcoidosis.重度慢性结节病患者外周血B细胞区室的内环境稳态紊乱和多种信号缺陷。
Clin Vaccine Immunol. 2011 Aug;18(8):1306-16. doi: 10.1128/CVI.05118-11. Epub 2011 Jun 8.
3
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
Diagnostics (Basel). 2024 Sep 30;14(19):2188. doi: 10.3390/diagnostics14192188.
4
A serum B-lymphocyte activation signature is a key distinguishing feature of the immune response in sarcoidosis compared to tuberculosis.与结核相比,结节病患者血清 B 淋巴细胞激活特征是其区别于结核病的免疫反应的关键特征。
Commun Biol. 2024 Sep 10;7(1):1114. doi: 10.1038/s42003-024-06822-1.
5
Imbalance of B-Cell Subpopulations in the Microenvironment of Sarcoidosis or Lung Cancer.肉芽肿病或肺癌微环境中 B 细胞亚群失衡。
Cells. 2024 Jul 29;13(15):1274. doi: 10.3390/cells13151274.
6
Sarcoidosis versus Granulomatous and Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency: A Comparative Review.结节病与常见变异型免疫缺陷中的肉芽肿性和淋巴细胞性间质性肺病:一项比较性综述。
Biomedicines. 2024 Jul 6;12(7):1503. doi: 10.3390/biomedicines12071503.
7
Emerging Therapeutic Options for Refractory Pulmonary Sarcoidosis: The Evidence and Proposed Mechanisms of Action.难治性肺结节病的新兴治疗选择:证据及拟议的作用机制
J Clin Med. 2023 Dec 19;13(1):15. doi: 10.3390/jcm13010015.
8
Sarcoidosis-related autoimmune inflammation in COVID-19 convalescent patients.新冠康复患者中与结节病相关的自身免疫性炎症
Front Med (Lausanne). 2023 Dec 21;10:1271198. doi: 10.3389/fmed.2023.1271198. eCollection 2023.
9
Initial behaviors and attitudes towards the COVID-19 vaccine in sarcoidosis patients: results of a self-reporting questionnaire.结节病患者对新冠疫苗的初始行为和态度:一份自我报告问卷的结果
Sarcoidosis Vasc Diffuse Lung Dis. 2023 Jun 29;40(2):e2023012. doi: 10.36141/svdld.v40i2.14388.
10
Association of and polymorphisms with sarcoidosis in a Greek patient cohort.希腊患者队列中[基因名称]和[基因名称]多态性与结节病的关联。 (注:原文中两个“and”之间缺少具体基因信息)
Arch Med Sci. 2022 Oct 16;19(3):672-677. doi: 10.5114/aoms/154019. eCollection 2023.
贝利尤单抗治疗系统性红斑狼疮患者的疗效和安全性:一项随机、安慰剂对照、3 期临床试验。
Lancet. 2011 Feb 26;377(9767):721-31. doi: 10.1016/S0140-6736(10)61354-2. Epub 2011 Feb 4.
4
Increased expression of B cell activation factor supports the abnormal expansion of transitional B cells in systemic lupus erythematosus.B 细胞活化因子表达增加支持系统性红斑狼疮中转态 B 细胞的异常扩增。
J Rheumatol. 2011 Apr;38(4):642-51. doi: 10.3899/jrheum.100214. Epub 2011 Jan 15.
5
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.鉴定人类中一种罕见的具有 IL-10 能力的 B 细胞亚群,该亚群类似于小鼠调节性 B10 细胞。
Blood. 2011 Jan 13;117(2):530-41. doi: 10.1182/blood-2010-07-294249. Epub 2010 Oct 20.
6
IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro.活化的人 B 细胞产生的白细胞介素-10 可调节体外 CD4(+)T 细胞的活化。
Eur J Immunol. 2010 Oct;40(10):2686-91. doi: 10.1002/eji.201040673.
7
Immunologic response of sarcoidosis.结节病的免疫反应。
Semin Respir Crit Care Med. 2010 Aug;31(4):390-403. doi: 10.1055/s-0030-1262208. Epub 2010 Jul 27.
8
CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.CD19(+)CD24(hi)CD38(hi) B 细胞在健康个体中表现出调节能力,但在系统性红斑狼疮患者中功能受损。
Immunity. 2010 Jan 29;32(1):129-40. doi: 10.1016/j.immuni.2009.11.009. Epub 2010 Jan 14.
9
Relapse of severe sarcoidosis with an uncommon peritoneal location after TNFalpha blockade. Efficacy of rituximab, report of a single case.肿瘤坏死因子α阻断治疗后罕见腹膜部位严重结节病复发。利妥昔单抗的疗效,1例报告
Joint Bone Spine. 2010 Jan;77(1):82-3. doi: 10.1016/j.jbspin.2009.11.005. Epub 2009 Dec 22.
10
Regulatory B cells as inhibitors of immune responses and inflammation.调节性B细胞作为免疫反应和炎症的抑制剂。
Immunol Rev. 2008 Aug;224:201-14. doi: 10.1111/j.1600-065X.2008.00661.x.